Omeros (OMER) Long-Term Debt Repayments (2010 - 2023)
Omeros recorded quarterly Long-Term Debt Repayments of $5.0 million in Q4 2023, down 96.02% quarter-over-quarter from $125.6 million in Q3 2020.
Omeros' Long-Term Debt Repayments history runs 11 years deep, the most recent figure standing at $5.0 million for Q4 2023.
- In Q4 2023, Long-Term Debt Repayments changed N/A year-over-year to $5.0 million; the TTM figure through Dec 2023 stood at $262.6 million (changed N/A YoY), while the FY2023 annual figure was $95.0 million, changed N/A from the prior year.
- Long-Term Debt Repayments came in at $5.0 million for Q4 2023 at Omeros, down from $125.6 million in the prior quarter.
- In the past five years, Long-Term Debt Repayments ranged from a high of $125.6 million in Q3 2020 to a low of $254000.0 in Q1 2019.
- A 3-year average of $43.6 million and a median of $5.0 million in 2023 frame the typical range for Long-Term Debt Repayments.
- On a YoY basis, Long-Term Debt Repayments climbed as much as 77.62% in 2019 and fell as far as 77.62% in 2019.
- Omeros' Long-Term Debt Repayments stood at $254000.0 in 2019, then soared by 49363.78% to $125.6 million in 2020, then slumped by 96.02% to $5.0 million in 2023.
- According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $5.0 million, $125.6 million, and $254000.0 for Q4 2023, Q3 2020, and Q1 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2020 | 125.64 Mn |
| Sep 30, 2020 | 125.64 Mn |
| Mar 31, 2019 | 254,000.00 |
| Mar 31, 2019 | 254,000.00 |
| Dec 31, 2018 | 131.71 Mn |
| Dec 31, 2018 | 131.71 Mn |
| Sep 30, 2018 | 129,000.00 |
| Sep 30, 2018 | 129,000.00 |
| Jun 30, 2018 | 93,000.00 |
| Jun 30, 2018 | 93,000.00 |
| Mar 31, 2018 | 143,000.00 |
| Mar 31, 2018 | 143,000.00 |
| Dec 31, 2017 | 179,000.00 |
| Dec 31, 2017 | 179,000.00 |
| Sep 30, 2017 | 128,000.00 |
| Sep 30, 2017 | 128,000.00 |
| Jun 30, 2017 | 73,000.00 |
| Jun 30, 2017 | 73,000.00 |
| Mar 31, 2017 | 51,000.00 |
| Mar 31, 2017 | 51,000.00 |
| Dec 31, 2016 | 70.08 Mn |
| Dec 31, 2016 | 70.08 Mn |
| Sep 30, 2016 | 28,000.00 |
| Sep 30, 2016 | 28,000.00 |
| Jun 30, 2016 | 34,000.00 |
| Jun 30, 2016 | 34,000.00 |
| Dec 31, 2015 | 27.26 Mn |
| Dec 31, 2015 | 27.26 Mn |
| Sep 30, 2015 | 2.40 Mn |
| Sep 30, 2015 | 2.40 Mn |
| Jun 30, 2015 | 2.34 Mn |
| Jun 30, 2015 | 2.34 Mn |
| Dec 31, 2014 | 18.54 Mn |
| Dec 31, 2014 | 18.54 Mn |
| Mar 31, 2014 | 1.46 Mn |
| Mar 31, 2014 | 1.46 Mn |
| Dec 31, 2012 | 1.60 Mn |
| Dec 31, 2012 | 1.60 Mn |
| Sep 30, 2012 | 1.57 Mn |
| Sep 30, 2012 | 1.57 Mn |
| Jun 30, 2012 | 1.53 Mn |
| Jun 30, 2012 | 1.53 Mn |
| Mar 31, 2012 | 1.50 Mn |
| Mar 31, 2012 | 1.50 Mn |
| Dec 31, 2011 | 996,000.00 |
| Dec 31, 2011 | 996,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Jun 30, 2011 | 13,000.00 |
| Jun 30, 2011 | 13,000.00 |
| Mar 31, 2011 | 28,000.00 |
| Mar 31, 2011 | 28,000.00 |
| Dec 31, 2010 | 8.88 Mn |
| Dec 31, 2010 | 8.88 Mn |
| Sep 30, 2010 | 1.42 Mn |
| Sep 30, 2010 | 1.42 Mn |